Allogene Therapeutics Ownership | Who Owns Allogene Therapeutics?
Allogene Therapeutics Ownership Summary
Allogene Therapeutics is owned by 97.66% institutional investors, 17.43% insiders. Fmr is the largest institutional shareholder, holding 18.48% of ALLO shares. American Funds SMALLCAP World A is the top mutual fund, with 3.30% of its assets in Allogene Therapeutics shares.
ALLO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Allogene Therapeutics | 97.66% | 17.43% | -15.09% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 31.26M | 18.48% | $72.83M |
| Tpg gp a | 18.72M | 11.07% | $43.61M |
| Blackrock | 16.45M | 9.72% | $38.32M |
| Vanguard group | 8.20M | 4.85% | $19.10M |
| State street | 7.67M | 4.53% | $17.87M |
| Capital world investors | 6.90M | 4.08% | $16.07M |
| Price t rowe associates inc /md/ | 5.79M | 3.42% | $13.49M |
| Primecap management co/ca/ | 5.67M | 3.35% | $13.21M |
| Woodline partners lp | 4.36M | 2.58% | $10.16M |
| Jpmorgan chase | 4.12M | 2.44% | $9.61M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vida ventures advisors | 1.80M | 4.58% | $4.19M |
| Superstring capital management lp | 689.91K | 2.03% | $1.61M |
| Wildcat capital management | 2.92M | 1.67% | $6.81M |
| Tpg gp a | 18.72M | 1.00% | $43.61M |
| Vestal point capital, lp | 2.20M | 0.38% | $5.13M |
| Lynx1 capital management lp | 2.23M | 0.34% | $5.19M |
| Dafna capital management | 605.10K | 0.34% | $1.41M |
| Frazier life sciences management | 2.87M | 0.31% | $6.68M |
| Coastal bridge advisors | 406.85K | 0.24% | $947.95K |
| Perceptive advisors | 2.73M | 0.15% | $6.35M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | 6.90M | 0.00% | 6.90M |
| Blackrock | 16.45M | 0.00% | 6.79M |
| Fmr | 31.26M | 0.00% | 5.89M |
| Perceptive advisors | 2.73M | 0.15% | 2.73M |
| Lynx1 capital management lp | 2.23M | 0.34% | 2.23M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Boxer capital | - | - | -3.85M |
| State street | 7.67M | 0.00% | -1.52M |
| Jpmorgan chase | 4.12M | 0.00% | -1.06M |
| Gsa capital partners llp | - | - | -835.34K |
| Octagon capital advisors lp | - | - | -720.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Capital world investors | 6.90M | 0.00% | 6.90M | $16.07M |
| Perceptive advisors | 2.73M | 0.15% | 2.73M | $6.35M |
| Lynx1 capital management lp | 2.23M | 0.34% | 2.23M | $5.19M |
| Jacobs levy equity management | 878.96K | 0.01% | 878.96K | $2.05M |
| Dafna capital management | 605.10K | 0.34% | 605.10K | $1.41M |
Sold Out
| Holder | Change |
|---|---|
| Toronto dominion bank | -27.00 |
| Dunhill financial | -70.00 |
| Lindbrook capital | -117.00 |
| Private wealth management group | -140.00 |
| Bell investment advisors | -161.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 171 | 7.55% | 165,168,429 | 25.95% | 97 | 1.62% | 94 | 23.68% | 41 | -4.65% |
| Mar 31, 2024 | 159 | -5.92% | 131,135,320 | 7.91% | 77 | 1.49% | 76 | -15.56% | 43 | -14.00% |
| Dec 31, 2023 | 169 | 11.92% | 121,517,475 | -5.63% | 72 | 1.22% | 90 | 9.76% | 50 | 47.06% |
| Sep 30, 2023 | 151 | -10.65% | 128,760,668 | -2.59% | 76 | 0.95% | 82 | 2.50% | 34 | -34.62% |
| Jun 30, 2023 | 169 | -5.06% | 132,189,252 | 13.33% | 90 | 1.38% | 80 | -11.11% | 52 | 4.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 6.90M | 3.30% | - |
| Fidelity Growth Compy Commingled Pl S | 4.61M | 2.21% | 28.98K |
| Fidelity Growth Compy Commingled Pl O | 4.58M | 2.19% | - |
| Fidelity Select Health Care | 4.35M | 2.08% | - |
| Vanguard Total Stock Mkt Idx Inv | 4.34M | 2.07% | - |
| Fidelity Series Small Cap Opps | 3.68M | 1.76% | - |
| Vanguard Capital Opportunity Inv | 3.57M | 1.71% | 18.60K |
| SPDR® S&P Biotech ETF | 3.50M | 1.67% | 38.68K |
| T. Rowe Price Health Sciences | 3.46M | 1.66% | -69.03K |
| iShares Russell 2000 ETF | 3.32M | 1.58% | -7.46K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 18, 2024 | MESSEMER DEBORAH M. | - | Sell | $42.49K |
| May 30, 2024 | Humer Franz B | - | Sell | $26.18K |
| May 16, 2024 | Belldegrun Arie | - | Buy | $5.00M |
| Jan 30, 2024 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | Buy | $683.05 |
| Dec 18, 2023 | MESSEMER DEBORAH M. | - | Sell | $50.32K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | 1 | 2 |
| 2024 Q1 | 1 | - |
| 2023 Q4 | - | 1 |
ALLO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools